Adipogen/anti-TRAIL (human), mAb (HS501)/AG-20B-0026-C100/100 ?g
一抗
商品編號
AG-20B-0026-C100
品牌
Adipogen
公司
Adipogen
公司分類(lèi)
Antibodies
Size
100 ?g
商品信息
More Information
Product Details
Synonyms
Apo-2L; TNFSF10; CD253
Product Type
Monoclonal Antibody
Properties
Clone
HS501
Isotype
Mouse IgG1
Source/Host
Purified from concentrated hybridoma tissue culture supernatant.
Immunogen/Antigen
Recombinant human TRAIL.
Application
Western Blot:
(1:1000)
Crossreactivity
Human
Specificity
Recognizes human TRAIL.
Purity
≥95% (SDS-PAGE)
Purity Detail
Protein G-affinity purified.
Concentration
1 mg/ml
Formulation
Liquid. In PBS containing 10% glycerol and 0.02% sodium azide.
Shipping and Handling
Shipping
BLUE ICE
Short Term Storage
+4°C
Long Term Storage
-20°C
Handling Advice
After opening, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
Use/St
ABI
lity
Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSD
S
Download PDF
Product Specification Sheet
Datasheet
Download PDF
TNF-related apoptosis-inducing ligand (TRAIL; Apo2L;CD253; TNFSF10) is a type II transmembrane protein of about 34kDa. Like most members of the tumor necrosis factor (TNF) superfamily of cytokines TRAIL can be cleaved at the cell surface by metalloproteases to form a soluble molecule. Active TRAIL forms trimers and specifically binds to five distinct receptors: TRAIL-R1 (DR4; Apo2; CD261; TNFRSF10A), TRAIL-R2 (DR5; KILLER; TRICK2A; TRICK2B; CD262; TNFRSF10B), TRAIL-R3 (DcR1; LIT; TRID; CD263; TNFRSF10C), TRAIL-R4 (DcR2; TRUNDD; CD264; TNFRSF10D), and osteoprotegerin (OPG; OCIF; TNFRSF11B). Trimerized TRAIL triggers apoptosis upon ligation of cell surface TRAIL-R1 and/or TRAIL-R2 by inducing the formation of the so-called multiprotein death-inducing signaling complex (DISC).
.
Product References
TNF-Related Apoptosis-Inducing Ligand Mediates Tumoricidal Activity of Human Monocytes Stimulated by Newcastle Disease Virus: B. Washburn, et al.; J. Immunol.?
170
, 1814 (2003)
Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape: V. Huber, et al.; Gastroenterology
128,
1796 (2005)
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors: T. Wenger, et al.; Cell Death Differ.
13,
1740 (2006)
Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence: J. Luetzkendorf, et al.; J. Cell. Mol. Med.
14,
2292 (2010)
產(chǎn)品貨號:3484.0